TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/4/23 20:51 | 3/31/23 | NLTX | Neoleukin Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Priti | WA | H | Former C | M.d | 0 | 0.00 | 0 | 10 | 37 | 37 | D | ||||||||||||||
4/4/23 20:51 | 4/3/23 | NLTX | Neoleukin Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Priti | WA | H | Former C | S.d | -3 | 0.6919 | 0 | -4 | -9 | 37 | D | ||||||||||||||
2/3/23 16:32 | 2/1/23 | NLTX | Neoleukin Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Priti | WA | O | Chief Me | M.d | 0 | 0.00 | 0 | 35 | 31 | D | |||||||||||||||
2/3/23 16:32 | 2/2/23 | NLTX | Neoleukin Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Priti | WA | O | Chief Me | S.d | -9 | 0.5972 | 0 | -14 | -32 | 31 | D | ||||||||||||||
5/3/22 19:16 | 4/30/22 | NLTX | Neoleukin Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Priti | WA | O | Chief Me | M.d | 0 | 0.00 | 0 | 10 | 6 | D | |||||||||||||||
5/3/22 19:16 | 5/2/22 | NLTX | Neoleukin Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Priti | WA | O | Chief Me | S.d | -7 | 1.22 | 0 | -6 | -46 | 6 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |